Humacyte (HUMA) Shares Issued (2020 - 2026)

Humacyte (HUMA) posted quarterly Shares Issued of $17.3 million for Q1 2026, down 3.83% quarter-over-quarter from $18.0 million in Q4 2025.

Humacyte (HUMA) Shares Issued (2020 - 2026) Analysis & Trends

Humacyte (HUMA) has reported Shares Issued for 5 consecutive years, with $17.3 million the latest figure, recorded in Q1 2026.

In Q1 2026, Shares Issued changed N/A year-over-year to $17.3 million; the TTM figure through Mar 2026 stood at $17.3 million (changed N/A YoY), while the FY2025 annual figure was $18.0 million, up 46.69% from the prior year.
Shares Issued declined to $17.3 million in Q1 2026 per HUMA's latest filing, from $18.0 million in the prior quarter.
Across five years, Shares Issued topped out at $18.0 million in Q4 2025 and bottomed at $12.3 million in Q4 2024.
Historically, Shares Issued has averaged $15.9 million across 3 years, with a median of $17.3 million in 2026.
On a YoY basis, Shares Issued climbed as much as 46.69% in 2025 and fell as far as 46.69% in 2025.
Humacyte's Shares Issued stood at $12.3 million in 2024, then surged by 46.69% to $18.0 million in 2025, then decreased by 3.83% to $17.3 million in 2026.
Business Quant data shows HUMA's Shares Issued at $17.3 million in Q1 2026, $18.0 million in Q4 2025, and $12.3 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	Humacyte	158.12 Mn	158.12 Mn	-825,000.00	17.40 Mn

Download Data